Local News Stoke Therapeutics Granted FDA Orphan Drug Designation for STK-001, an Investigational New Treatment for Dravet Syndrome Business Wire | August 9, 2019 Stoke Therapeutics, Inc., (Nasdaq: STOK), a biotechnology company pioneering a new way to treat the…sciencecityAugust 9, 2019 Read More
Local News LexaGene Nabs CDC and FDA Approval for New Antibiotic Resistance Test BioSpace | August 8, 2019 With increasing concerns over the rise of drug-resistant pathogens wreaking havoc on the healthcare system,…sciencecityAugust 8, 2019 Read More
Local News A Vaccine to Prevent Opioid Overdose? Boston Children's Hospital | August 8, 2019 Sharon Levy, MD, MPH, who directs the Adolescent Substance Use and Addiction Program (ASAP)at Boston Children’s…sciencecityAugust 8, 2019 Read More
Local News Leap Presents Positive Clinical Results for the Combination of DKN-01 plus Keytruda® and Provides DKN-01 Program Update Leap Therapeutics | August 8, 2019 Leap Therapeutics, Inc. (NASDAQ: LPTX) today announced that its anti-Dickkopf-1 (DKK1) antibody, DKN-01, in combination with Merck's anti-PD-1 antibody, Keytruda® (pembrolizumab),…sciencecityAugust 8, 2019 Read More
Local News Model Predicts Cognitive Decline Due to Alzheimer’s, Up to Two Years Out MIT News | August 6, 2019 Researchers hope the system can zero in on the right patients to enroll in clinical…sciencecityAugust 6, 2019 Read More
Local News Legal Fight over Broad Institute’s Patent for CRISPR Gene Editing Flares Up Again Boston Business Journal | August 5, 2019 The legal battle over a method of altering a person’s genes — potentially worth billions…sciencecityAugust 5, 2019 Read More
Local News Can Collagen Help Fix Injured Tendons? These Tissue Engineers Think So News@Northeastern | August 2, 2019 Tendon injuries can happen in an instant. With a loud pop and a sharp pain,…sciencecityAugust 2, 2019 Read More
Local News Speeding Up Drug Discovery for Brain Diseases MIT News | August 2, 2019 Whitehead Institute team finds drugs that activate a key brain gene; initial tests in cells…sciencecityAugust 2, 2019 Read More
Local News Biogen and Alkermes’ New MS Drug has Fewer GI Side Effects than Tecfidera BioSpace | August 1, 2019 Biogen, headquartered in Cambridge, Massachusetts, and Alkermes, based in Dublin, announced positive topline data from EVOLVE-MS-2, a Phase…sciencecityAugust 1, 2019 Read More
Local News Alexandria Planning Necco Street Life-Science Campus Near GE HQ Boston Business Journal | August 1, 2019 Life science real-estate development firm Alexandria Real Estate Equities expects that it could develop an…sciencecityAugust 1, 2019 Read More